|Previous Section||Index||Home Page|
Rosie Cooper: To ask the Secretary of State for Health what the (a) average and (b) target waiting time to see a (i) psychiatrist and (ii) psychologist was for (A) adults and (B) children in the West Lancashire constituency in each of the last five years. 
The maximum waiting time for a first out-patient appointment with a psychiatry consultant is 17 weeks.
17 Jan 2006 : Column 1299W
From the end of 2005, the target will reduce to 13 weeks. The maximum waiting time for in-patient treatment under the care of a psychiatry consultant is nine months. From the end of 2005, the target will reduce to six months.
17 Jan 2006 : Column 1300W
Information on the estimated average waiting from general practitioner written referral to first out-patient appointment with a psychiatry consultant working in national health services organisations covering the West Lancashire constituency is shown in the table.
|Effective length of wait from receipt of GP written referral request to first out-patient attendance (weeks)|
|North Sefton and West Lancashire Community NHS trust (provider based)|
|Quarter September:||0 to <4||4 to <13||13 to <26||26 plus||Median wait|
|Effective length of wait from receipt of GP written referral request to first out-patient|
|Quarter September:||0 to<4||4 to<13||13 to <17||17 to <21||21 plus||Median wait|
|Lancashire Care NHS Trust (provider trust)|
|West Lancashire PCT (provider based)|
|West Lancashire PCT (commissioner based)|
Mr. Byrne: The information requested is not collected centrally. Current funding arrangements mean that primary care trusts are allocated resources on the basis of the relative needs of their populations. It is for primary care trusts in partnership with strategic health authorities and other local stakeholders to determine how best to use their funds to meet national and local priorities.
Rosie Cooper: To ask the Secretary of State for Health what the waiting time is for people to be taken on by an NHS dentist in (a) West Lancashire constituency and (b) Lancashire; and if she will make a statement. 
Primary care trusts (PCTs) across Lancashire received some £1.9 million in access funding in 200405 to improve access to dentistry. The Cumbria and Lancashire strategic health authority (SHA) advise that from this money, the equivalent of 16.1 whole-time additional dentists are now working within the Lancashire area. PCTs across Lancashire have been
17 Jan 2006 : Column 1301W
working with dental practices to support them in moving over to the new personal dental service (PDS) contract. As at the beginning of December 2005, 37 per cent. of practices had converted to PDS. The SHA advises that all PDS contracts have growth included in them for extra national health service registrations and practices have been increasing their registrations on a steady basis.
Mr. Byrne: It is for primary care trusts in partnership with strategic health authorities, local authorities and other local stakeholders to determine how best to use their funds to meet national and local priorities for improving health, tackling health inequalities and modernising services. This process provides the means for addressing local needs within the health community including the provision of health visiting services. All primary care trusts will commission these services to meet the needs of their local population.
Mr. Hancock: To ask the Secretary of State for Health what action she is taking to ensure that the social eligibility criteria applied by primary care trusts to couples seeking infertility treatment is the same throughout the country. 
Caroline Flint: The primary responsibility for the implementation of the clinical guideline on the assessment and treatment of people with fertility problems produced in February 2004 by the National Institute for Health and Clinical Excellence rests with the national health service at local level, in discussion with patients' groups and local health bodies. Local policies will reflect local needs and priorities.
Mr. Spellar: To ask the Secretary of State for Health pursuant to the answer of 7 December 2005, Official Report, column 1406W, on influenza vaccines, what steps she is taking (a) to expand and (b) to diversify production capacity for production of influenza vaccine. 
We have invited manufacturers to tender for a contract to supply pandemic flu vaccine once the pandemic strain is known. The United Kingdom will need approximately 120 million doses to be available as soon as possible. This proposal to purchase in advance the capacity needed to make pandemic flu vaccine will make sure that an effective vaccine is available for use in the UK as quickly as possible after a flu pandemic starts.
17 Jan 2006 : Column 1302W
We are finalising a contract for the purchase of two to three million doses of vaccine against the H5N1 strain currently circulating in South East Asia and other areas. This vaccine can be used for research and for possible use for healthcare workers in an emergency, and may provide some limited protection against a pandemic emerging from that source. We hope to award this contract shortly and should receive some stocks in the next few months. Award of these contracts will provide manufacturers with resource to develop vaccines and increase production capacity.
We have already met with several manufacturers to discuss a range of vaccine production technologies, in addition to the standard egg based technology, such as DNA and cell-culture vaccines which may allow production capacity to be increased.
Caroline Flint: On 19 October 2005, the Chief Medical Officer announced that the Department is inviting manufacturers to tender for a contract to supply pandemic flu vaccine once the pandemic strain is known. The United Kingdom will need approximately 120 million doses to be available as soon as possible. The proposal to purchase in advance the capacity needed to make pandemic flu vaccine will make sure that an effective vaccine is available for use in the UK as quickly as possible after a flu pandemic starts.
On 20 July 2005, the Department invited manufacturers to tender for a limited supply of H5N1 vaccine. The move is part of the work to prepare for and reduce the impact of a possible flu pandemic. We hope to award this contract shortly.
|Next Section||Index||Home Page|